Drug Type Fusion protein |
Synonyms Dianexin ophthalmic, Recombinant human annexin A5 ophthalmic |
Target |
Action stimulants |
Mechanism uPA stimulants(Urokinase plasminogen activator stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eye Diseases | Phase 2 | - | - |